UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial

The lancet oncology, 2016-08, Vol.17 (8), p.1094-1104

2016

Volltextzugriff (PDF)

ctDNA analysis identifies clinically meaningful resistance mutations in EGFR mutated NSCLC on osimertinib: a case report

Lung cancer (Amsterdam, Netherlands), 2022-03, Vol.165, p.S74-S75

2022

Volltextzugriff (PDF)

161 - ctDNA analysis identifies clinically meaningful resistance mutations in EGFR mutated NSCLC on osimertinib: a case report

Lung cancer (Amsterdam, Netherlands), 2022-03, Vol.165, p.S74-S75

2022

Volltextzugriff (PDF)

Phase 1/2 study of fractionated 131I-rituximab in low-grade B-cell lymphoma: the effect of prior rituximab dosing and tumor burden on subsequent radioimmunotherapy

Blood, 2009-02, Vol.113 (7), p.1412-1421

2009

Volltextzugriff (PDF)

76 - Nephrotoxicity in first-line systemic therapy for non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2022-03, Vol.165, p.S36-S37

2022

Volltextzugriff (PDF)

Nephrotoxicity in first-line systemic therapy for non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2022-03, Vol.165, p.S36-S37

2022

Volltextzugriff (PDF)

Fractionated 90Y-Ibritumomab Tiuxetan Radioimmunotherapy As an Initial Therapy of Follicular Lymphoma: An International Phase II Study in Patients Requiring Treatment According to GELF/BNLI Criteria

Journal of clinical oncology, 2014-01, Vol.32 (3), p.212-218

2014

Volltextzugriff (PDF)

151 Patient outcomes following Lung SABR: The University Hospitals Dorset Experience

Lung cancer (Amsterdam, Netherlands), 2024-04, Vol.190, p.107712, Article 107712

2024

Volltextzugriff (PDF)

Modern chemoradiation for lung cancer in Dorset. Real world experience with adjuvant durvalumab

Lung cancer (Amsterdam, Netherlands), 2021-06, Vol.156, p.S39-S40

2021

Volltextzugriff (PDF)

Prevalence, treatment and outcomes of patients with advanced, non-squamous NSCLC (nsNSCLC) harbouring ALK or ROS1 gene-rearrangements in Dorset

Lung cancer (Amsterdam, Netherlands), 2021-06, Vol.156, p.S36-S37

2021

Volltextzugriff (PDF)

Interesting case of immunotherapy related pneumonitis presenting as radiation pneumonitis

Lung cancer (Amsterdam, Netherlands), 2021-06, Vol.156, p.S77-S78

2021

Volltextzugriff (PDF)

A new anti-idiotype antibody capable of binding rituximab on the surface of lymphoma cells

Blood, 2004-10, Vol.104 (8), p.2540-2542

2004

Volltextzugriff (PDF)

P2.05-055 90 Day Mortality and Survival Following Radical Radiotherapy for Non-Small Cell Lung Cancer Treated in the Dorset Cancer Centre, UK: Topic: Toxicities

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1065-S1066

2017

Volltextzugriff (PDF)

P2.05-055 90 Day Mortality and Survival Following Radical Radiotherapy for Non-Small Cell Lung Cancer Treated in the Dorset Cancer Centre, UK

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1065-S1066

2017

Volltextzugriff (PDF)

Apparent modulation of CD20 by rituximab: an alternative explanation

Blood, 2004-05, Vol.103 (10), p.3989-3990

2004

Volltextzugriff (PDF)

An update on health-related quality of life from the PROCLIPI study

European journal of cancer (1990), 2021-10, Vol.156, p.S30

2021

Volltextzugriff (PDF)

COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss

European journal of cancer (1990), 2017-12, Vol.87, p.75-83

2017

Volltextzugriff (PDF)

Changes in management for patients with lung cancer referred for radical radiotherapy during the first wave of the COVID 19 pandemic in the UK (COVID-RT Lung)

Lung cancer (Amsterdam, Netherlands), 2021-06, Vol.156, p.S14-S14

2021

Volltextzugriff (PDF)

The use of fused PET/CT images for patient selection and radical radiotherapy target volume definition in patients with non-small cell lung cancer: Results of a prospective study with mature survival data

Radiotherapy and oncology, 2013-03, Vol.106 (3), p.292-298

2013

Volltextzugriff (PDF)

Quality of life in patients with mycosis fungoides and Sezary syndrome is significantly worse in female patients, Sézary syndrome and those with more extensive skin involvement

European journal of cancer (1990), 2018-09, Vol.101, p.S39-S39

2018

Volltextzugriff (PDF)

Lymph node imaging in patch/plaque mycosis fungoides; enlarged LN are infrequent but lymphomatous nodal involvement may occur and upstage patients to advanced disease

European journal of cancer (1990), 2018-09, Vol.101, p.S25-S26

2018

Volltextzugriff (PDF)

Phase 1/2a study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma

Blood advances, 2020-09, Vol.4 (17), p.4091-4101

2020

Volltextzugriff (PDF)

Fractionated 90 Y-Ibritumomab Tiuxetan Radioimmunotherapy As an Initial Therapy of Follicular Lymphoma: An International Phase II Study in Patients Requiring Treatment According to GELF/BNLI Criteria

Journal of clinical oncology, 2014-01, Vol.32 (3), p.212-218

2014

Volltextzugriff (PDF)

Lesson learnt: severe skin reaction to somatostatin analogue injections

Endocrine Abstracts, 2018-11

2018

Volltextzugriff (PDF)

Abstract C184: Validation of an ELISA for the determination of Rituximab pharmacokinetics in clinical trials subjects

Molecular cancer therapeutics, 2009-12, Vol.8 (12_Supplement), p.C184-C184

2009

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(32)

Publikationsform

Sprache

Englisch
(37)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial

ctDNA analysis identifies clinically meaningful resistance mutations in EGFR mutated NSCLC on osimertinib: a case report

161 - ctDNA analysis identifies clinically meaningful resistance mutations in EGFR mutated NSCLC on osimertinib: a case report

Phase 1/2 study of fractionated 131I-rituximab in low-grade B-cell lymphoma: the effect of prior rituximab dosing and tumor burden on subsequent radioimmunotherapy

76 - Nephrotoxicity in first-line systemic therapy for non-small cell lung cancer

Nephrotoxicity in first-line systemic therapy for non-small cell lung cancer

Fractionated 90Y-Ibritumomab Tiuxetan Radioimmunotherapy As an Initial Therapy of Follicular Lymphoma: An International Phase II Study in Patients Requiring Treatment According to GELF/BNLI Criteria

151 Patient outcomes following Lung SABR: The University Hospitals Dorset Experience

Modern chemoradiation for lung cancer in Dorset. Real world experience with adjuvant durvalumab

Prevalence, treatment and outcomes of patients with advanced, non-squamous NSCLC (nsNSCLC) harbouring ALK or ROS1 gene-rearrangements in Dorset

Interesting case of immunotherapy related pneumonitis presenting as radiation pneumonitis

A new anti-idiotype antibody capable of binding rituximab on the surface of lymphoma cells

P2.05-055 90 Day Mortality and Survival Following Radical Radiotherapy for Non-Small Cell Lung Cancer Treated in the Dorset Cancer Centre, UK: Topic: Toxicities

P2.05-055 90 Day Mortality and Survival Following Radical Radiotherapy for Non-Small Cell Lung Cancer Treated in the Dorset Cancer Centre, UK

Apparent modulation of CD20 by rituximab: an alternative explanation

An update on health-related quality of life from the PROCLIPI study

COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss

Changes in management for patients with lung cancer referred for radical radiotherapy during the first wave of the COVID 19 pandemic in the UK (COVID-RT Lung)

The use of fused PET/CT images for patient selection and radical radiotherapy target volume definition in patients with non-small cell lung cancer: Results of a prospective study with mature survival data

Quality of life in patients with mycosis fungoides and Sezary syndrome is significantly worse in female patients, Sézary syndrome and those with more extensive skin involvement

Lymph node imaging in patch/plaque mycosis fungoides; enlarged LN are infrequent but lymphomatous nodal involvement may occur and upstage patients to advanced disease

Phase 1/2a study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma

Fractionated 90 Y-Ibritumomab Tiuxetan Radioimmunotherapy As an Initial Therapy of Follicular Lymphoma: An International Phase II Study in Patients Requiring Treatment According to GELF/BNLI Criteria

Lesson learnt: severe skin reaction to somatostatin analogue injections

Abstract C184: Validation of an ELISA for the determination of Rituximab pharmacokinetics in clinical trials subjects

Suchergebnisse filtern